Stockreport

Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host...

Ironwood Pharmaceuticals, Inc. - Class A  (IRWD) 
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.ironwoodpharma.com
PDF – First prospective trial of a glucagon-like peptide (GLP-2) analog in SR GI aGVHD –– Results up to Day 91 show that apraglutide in SR GI aGVHD was well-tolerated with a [Read more]